CORRECTION article

Front. Pharmacol., 21 November 2022

Sec. Cardiovascular and Smooth Muscle Pharmacology

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1080645

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities

  • 1. The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd, Tianjin, China

  • 2. PriMed Non-Human Primate Research Center of Sichuan PriMed Shines Bio-Tech Co., Ltd., Ya’an, Sichuan, China

  • 3. China Pharmaceutical University, Nanjing, China

  • 4. Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

  • 5. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China

Article metrics

View details

1

Citations

1,7k

Views

997

Downloads

In the original article, there was an error in the name of Traditional Chinese Medicine throughout the article. The name was displayed as “QiShenYiQi Dripping Pills (T101)” or “QSYQ (T101)”. The corrected name is “QiShenYiQi Dripping Pills” or “QSYQ”. The code number T101 has been deleted in the title and Figure 1.

FIGURE 1

FIGURE 1

The flowchart of the study.

The corrected title appears below.

“Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities”.

The corrected Figure 1 and its caption “The flowchart of the study.” appear below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

heart failure, QSYQ, SHR, network pharmacology, metabolomics

Citation

Zhang J, Yang Z, Jia X, Li X, Wang X, Rong H, Liang Y, Zeng W, Jia W and Ma X (2022) Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities. Front. Pharmacol. 13:1080645. doi: 10.3389/fphar.2022.1080645

Received

26 October 2022

Accepted

04 November 2022

Published

21 November 2022

Volume

13 - 2022

Edited and reviewed by

Wei Deng, Renmin Hospital of Wuhan University, China

Updates

Copyright

*Correspondence: Wei Jia, ; Xiaohui Ma,

This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics